Trv Gp Iv, LLC has filed its 13F form on November 06, 2024 for Q3 2024 where it was disclosed a total value porftolio of $162 Million distributed in 3 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Tango Therapeutics, Inc. with a value of $130M, Pliant Therapeutics, Inc. with a value of $23.9M, and Fulcrum Therapeutics, Inc. with a value of $8.37M.

Examining the 13F form we can see an decrease of $40.1M in the current position value, from $202M to 162M.

Trv Gp Iv, LLC is based out at Boston, MA

Below you can find more details about Trv Gp Iv, LLC portfolio as well as his latest detailed transactions.

Portfolio value $162 Million
Healthcare: $162 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 3
  • Current Value $162 Million
  • Prior Value $202 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 06, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Trv Gp Iv, LLC Portfolio

Follow Trv Gp Iv, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trv Gp Iv, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trv Gp Iv, LLC with notifications on news.